Post-Interleukin 17
(Unterschied zwischen Versionen)
| Zeile 4: | Zeile 4: | ||
{{tp|p=32339777|t=2020. May IL-17 have a role in COVID-19 infection?|pdf=|usr=}} | {{tp|p=32339777|t=2020. May IL-17 have a role in COVID-19 infection?|pdf=|usr=}} | ||
{{tp|p=32504739|t=2020. Interleukin-17: A potential therapeutic target in COVID-19.|pdf=|usr=007}} | {{tp|p=32504739|t=2020. Interleukin-17: A potential therapeutic target in COVID-19.|pdf=|usr=007}} | ||
| + | {{tp|p=32475041|t=2020. Potential role of Anti-IL-17 in COVID-19 treatment.|pdf=|usr=007}} | ||
Version vom 28. Juni 2020, 11:11 Uhr
32353597 ä. SARS-COV2 INFECTION AND LUNG CANCER PATIENTS: the potential role of IL17 target therapy
32358580 ä. COVID-19: a case for inhibiting IL-17?
32302707 ä. Could IL-17 represent a new therapeutic target for the treatment and/or management of COVID-19-related respiratory syndrome?: This paper is dedicated to Sofia Maione born during COVID-19 outbreak frisch geboren und schon publiziert...
32339777 2020. May IL-17 have a role in COVID-19 infection?
32504739 2020. Interleukin-17: A potential therapeutic target in COVID-19.
32475041 2020. Potential role of Anti-IL-17 in COVID-19 treatment.
